Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No Single Market, no single prices

This article was originally published in Scrip

Executive Summary

The European Commission is planning to review the “Transparency Directive” on pricing and reimbursement. And so it seems somewhat ironic that the response from the European Industry Body, EFPIA, has been to say that nothing in the directive must compromise the “confidentiality” of pricing arrangements between companies and payers. Is EFPIA forging new ground in double-speak by asking for secrecy to be written into policies on openness?

Latest Headlines
See All
UsernamePublicRestriction

Register

SC013148

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel